June 01, 2025 a 03:43 pm
DHR: Fundamental Ratio Analysis - Danaher Corporation
Danaher Corporation, a pivotal player in the healthcare and diagnostics sector, has demonstrated resilience and steady growth. As it continues to innovate across its diverse segments, this stock remains a reliable choice for long-term investors. However, potential fluctuations in global markets pose a risk to its trajectory.
Fundamental Rating
Danaher Corporation shows a robust fundamental profile, with strengths in cash flow management and return on equity and assets.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 2 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
Examining previous scores can highlight trends and potential areas of concern or improvement.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-05-30 | 3 | 4 | 4 | 4 | 2 | 1 | 2 |
Analyst Price Targets
The price target estimates suggest strong potential gains based on current and projected industry performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| $275 | $231 | $240 | $249.2 |
Analyst Sentiment
The sentiment remains predominantly positive, with a significant inclination towards buying.
| Rating | Count | Visual |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 29 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Danaher Corporation presents a strong investment opportunity, particularly for those seeking exposure in the healthcare and diagnostics sector. Its solid fundamentals, coupled with positive analyst sentiment, underscore its potential for long-term growth. However, investors should remain cautious of market volatilities and sector-specific risks. Overall, Danaher continues to be a dominant force, well-positioned to capitalize on future innovations.